Table 5.

Predictors for clinical response.

Variables	P-value	P-value
	(Propranolol group)	(Timolol group)
Gender	0.53	0.32
Age at treatment initiation	0.02*	0.04*
Duration of treatment	0.19	0.52
Lesion location	0.29	0.27
Lesion size	0.53	0.24
Gestational age	0.37	0.43
Progesterone use during pregnancy	0.28	0.31

^*p < 0.05 was considered as significant.